Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Aim, Astrazeneca, Bitterroot, Cognition, Inflammasome, Inmune, Intellia, Merck & Co., Selection.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen, Atom, Caliway, Immutep, Lisata, Recce.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Arbele, Biocardia, Caliway, Can-Fite, Nkgen, Recce.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aphaia, Biovie, Eyenovia, Hookipa, Immunitybio, Kinevant, Pep-Therapy, Roivant, Sarton, Vistagen.